Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation

Matthias Staudinger, PhD, Christian Kellner, PhD, Matthias Peipp, PhD, Natalie Schub, MD, Andreas Humpe, MD, Martin Gramatzki, MD

Blood (2013) 122 (21): 3972.

https://doi.org/10.1182/blood.V122.21.3972.3972

Published: 2013

Journal Articles

Selective Inhibition Of The PI3K-Alpha Isoform Blocks Myeloma Cell Growth and Survival

Andreas Guenther, MD, Renate Burger, PhD, Wolfram Klapper, Matthias Staudinger, PhD, Martin Gramatzki, MD

Blood (2013) 122 (21): 5364.

https://doi.org/10.1182/blood.V122.21.5364.5364

Published: 2013

Journal Articles

Maturation of Monocyte-Derived Dendritic Cells Induced by Dual Targeting of Endocytosis Receptor and CD40

Matthias Staudinger, PhD, Inga Rebekka Catenhusen, Matthias Peipp, PhD, Christian Kellner, PhD, Roland Repp, MD, Martin Gramatzki, MD

Blood (2010) 116 (21): 4293.

https://doi.org/10.1182/blood.V116.21.4293.4293

Published: 2010

Journal Articles

The Novel JAK2 Inhibitor NVP-BSK805 Has Cytotoxic Activity on Malignant Plasma Cells

Renate Burger, PhD, Franziska Rademacher, Matthias Staudinger, PhD, Matthias Peipp, PhD, Andreas Güunther, MD, Martin Gramatzki, MD

Blood (2010) 116 (21): 2993.

https://doi.org/10.1182/blood.V116.21.2993.2993

Published: 2010

Journal Articles

Potent Activation of Healthy Donor T-Cells Specific for Mantle Cell Lymphoma Immunoglobulin Derived Peptides by CD40- and TLR7/8-Ligand Matured Dendritic Cells in Vitro

Liane Bergmann, Matthias Staudinger, PhD, Christiane Pott, MD, Ingrid Bolz, Martin Gramatzki, MD, Michael Kneba, MD, PhD, Benedikt Gahn, MD

Blood (2008) 112 (11): 3502.

https://doi.org/10.1182/blood.V112.11.3502.3502

Published: 2008

Journal Articles

Efficient Lysis of Myeloma Cells by CD16 Positive Effector Cells with Recombinant Single Chain Bispecific Antibodies Targeting HM1.24.

Matthias Peipp, PhD, Claudia Ehlert, Matthias Staudinger, PhD, Joerg Bruenke, PhD, Georg Fey, PhD, Martin Gramatzki, MD, Roland Repp, MD

Blood (2007) 110 (11): 2752.

https://doi.org/10.1182/blood.V110.11.2752.2752

Published: 2007

NARROW

Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation

Selective Inhibition Of The PI3K-Alpha Isoform Blocks Myeloma Cell Growth and Survival

Maturation of Monocyte-Derived Dendritic Cells Induced by Dual Targeting of Endocytosis Receptor and CD40

The Novel JAK2 Inhibitor NVP-BSK805 Has Cytotoxic Activity on Malignant Plasma Cells

Potent Activation of Healthy Donor T-Cells Specific for Mantle Cell Lymphoma Immunoglobulin Derived Peptides by CD40- and TLR7/8-Ligand Matured Dendritic Cells in Vitro

Efficient Lysis of Myeloma Cells by CD16 Positive Effector Cells with Recombinant Single Chain Bispecific Antibodies Targeting HM1.24.

Email alerts

ASH Publications

American Society of Hematology

Targeting CD96 For Antibody Based Elimination Of Leukemic Stem Cells In AML: A New Strategy In Stem Cell Transplantation

Selective Inhibition Of The PI3K-Alpha Isoform Blocks Myeloma Cell Growth and Survival

Maturation of Monocyte-Derived Dendritic Cells Induced by Dual Targeting of Endocytosis Receptor and CD40

The Novel JAK2 Inhibitor NVP-BSK805 Has Cytotoxic Activity on Malignant Plasma Cells

Potent Activation of Healthy Donor T-Cells Specific for Mantle Cell Lymphoma Immunoglobulin Derived Peptides by CD40- and TLR7/8-Ligand Matured Dendritic Cells in Vitro

Efficient Lysis of Myeloma Cells by CD16 Positive Effector Cells with Recombinant Single Chain Bispecific Antibodies Targeting HM1.24.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only